Tirupati Forge Secures Industrial License For 155mm Artillery Shells; Pilot Production In December 2026

Market snapshot: Tirupati Forge Limited has received a strategic industrial license under the Indian Arms Act, 1959, to manufacture empty artillery shells across major calibers up to 155mm. This critical regulatory milestone clears the path for the company to kick-start its pilot production run in December 2026 at its advanced defense center in Rajkot, Gujarat.

Data Snapshot

• Tirupati Forge obtained an industrial license covering empty artillery shell manufacturing up to 155mm, encompassing HE M107, HE L15A1, and Extended Range Full Bore variants.
• The company's advanced defense center has an initial production capacity of 1.5 lakh units of shell bodies annually.
• Pilot production runs are scheduled to start in December 2026, with plans to rapidly transition into full-scale commercialization.

What's Changed

• The acquisition of the industrial license under the Indian Arms Act, 1959, marks a structural shift from Tirupati Forge's core automotive and industrial flange business into high-value defense ammunition manufacturing.
• With a newly commissioned defense facility built to NATO standards, the company will transition from a trial phase to pilot manufacturing in December 2026.

Key Takeaways

• Tirupati Forge is now authorized to produce empty artillery shells in multiple major calibers: 105mm, 120mm, 122mm, 125mm, 130mm, 152mm, and 155mm.
• The license covers highly specialized 155mm ammunition variants, including HE M107, Extended Range Full Bore, and Base Bleed shell bodies.
• Initial plant capability is set at 1.5 lakh units per year, establishing an immediate foundation for high-volume defense exports and domestic supply.
• Pilot production starting in December 2026 initiates the final step before full-scale commercial monetization of the defense facility.

SAHI Perspective

The formal grant of this industrial license is a significant regulatory clearance that de-risks Tirupati Forge's entry into the defense ecosystem. Previously, the company completed trial production and hot trials, but could not commercialize without this official Arms Act authorization. While base earnings have faced margin pressure from steel price volatility, this defense foray provides access to a high-EBITDA margin segment. The NATO-standard compliance of the facility is strategically timed to capture substantial export demand as Western nations look to diversify their ammunition supply networks.

Market Implications

This regulatory approval is highly positive for Tirupati Forge's long-term valuation, as it transitions the stock from a low-margin commodity forgings player to an active defense supplier. Over time, as the 1.5 lakh unit capacity ramps up, it could unlock sustainable, high-margin revenue streams that offset the volatility of its core export flange business.

Trading Signals

Market Bias: Bullish

The regulatory approval of the industrial license removes the final major hurdle for Tirupati Forge's entry into the high-margin defense segment. This milestone enables the company to commercialize its 1.5 lakh unit annual capacity facility, driving long-term earnings growth.

Overweight: Defence Manufacturing, High-Precision Engineering

Trigger Factors:

• Commencement of pilot manufacturing runs in December 2026
• Securing of first domestic or international purchase order for 155mm shell bodies
• Stabilization of operating margins as high-margin defense revenue starts reflecting in late FY27

Time Horizon: Medium-term (3-12 months)

Industry Context

The global demand for 155mm artillery shells has surged exponentially due to ongoing geopolitical conflicts and European stockpile rebuilding. This has created a persistent global supply deficit, prompting NATO nations and other global purchasers to look beyond traditional Western defense contractors. Indian engineering firms with advanced forging capabilities, such as Tirupati Forge, are leveraging this demand gap. Producing these precision components in India is highly cost-efficient, allowing local manufacturers to deliver high-quality, certified shell bodies at competitive international prices.

Key Risks to Watch

• Execution risk associated with scaling from pilot runs in December 2026 to full-scale commercial volumes.
• Potential changes in government defense procurement policies or tender guidelines.
• Prolonged timeline in receiving product certification from domestic or global defense authorities before final shipment.

Recent Developments

On September 1, 2026, Tirupati Forge released its annual report for FY26, showing a 41.3% YoY jump in operations revenue to ₹162.48 crore and a 175.1% rise in operating cash flows to ₹16.09 crore, alongside the commissioning of its NATO-standard defense manufacturing facility. Earlier, on August 13, 2026, the company reported mixed Q1 FY27 results, with revenue rising 18% YoY to ₹38.43 crore, while standalone net profit declined 14.3% YoY to ₹1.22 crore due to higher operational overheads.

Closing Insight

By securing the necessary Arms Act license, Tirupati Forge has transformed from a speculative defense entrant into a validated supplier with a clear commercialization timeline. While near-term financials reflect the heavy setup costs of this diversification, the commencement of pilot runs in December 2026 represents a major pivot point that could re-rate the stock in the medium to long term.

High Performance Trading with SAHI.